View:

Download DOC

Download PDF

Download XLS

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Entera Bio Ltd. (Name of Issuer)

Ordinary Shares, par value of NIS 0.0000769 (Title of Class of Securities)

(CUSIP Number)

07/28/2026 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity Fund Holdings, L.P.
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 4,330,882.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 4,330,882.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 4,330,882.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 2.5 %
12	Type of Reporting Person (See Instructions) PN

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity Co-Invest, L.P.
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 2,718,137.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 2,718,137.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 2,718,137.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 1.6 %
12	Type of Reporting Person (See Instructions) PN

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity Co-Invest (Cycle 3), L.P.
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 4,768,382.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 4,768,382.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 4,768,382.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 2.8 %
12	Type of Reporting Person (See Instructions) PN

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity, LLC
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 11,817,401.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 11,817,401.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 11,817,401.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 6.9 %
12	Type of Reporting Person (See Instructions) OO

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity Cayman Fund, L.P.
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 437,500.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 437,500.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 437,500.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 0.3 %
12	Type of Reporting Person (See Instructions) PN

SCHEDULE 13G

CUSIP No.

1	Names of Reporting Persons Vivo Opportunity Cayman, LLC
2	Check the appropriate box if a member of a Group (see instructions)   (a)   (b)
3	Sec Use Only
4	Citizenship or Place of Organization CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:	5 Sole Voting Power 437,500.00 6 Shared Voting Power 0.00 7 Sole Dispositive Power 437,500.00 8 Shared Dispositive Power 0.00
9	Aggregate Amount Beneficially Owned by Each Reporting Person 437,500.00
10	Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11	Percent of class represented by amount in row (9) 0.3 %
12	Type of Reporting Person (See Instructions) OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Entera Bio Ltd.
(b)	Address of issuer's principal executive offices: Kiryat Hadassah, Minrav Building Fifth Floor Jerusalem, Israel 9112002
Item 2.
(a)	Name of person filing: Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. and their General Partner Vivo Opportunity, LLC. Vivo Opportunity Cayman Fund, L.P. and its General Partner Vivo Opportunity Cayman, LLC.
(b)	Address or principal business office or, if none, residence: 192 Lytton Avenue, Palo Alto, CA 94301
(c)	Citizenship: Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. are Delaware limited partnerships. Vivo Opportunity, LLC is a Delaware limited liability company. Vivo Opportunity Cayman Fund, L.P. is a Cayman Islands limited partnership. Vivo Opportunity Cayman, LLC is a Cayman Islands limited liability company.
(d)	Title of class of securities: Ordinary Shares, par value of NIS 0.0000769
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),        please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Vivo Opportunity, LLC may be deemed to beneficially own an aggregate of 11,817,401 shares of the Issuer's securities, consisting of (i) 4,330,882 Ordinary Shares of the Issuer held of record by Vivo Opportunity Fund Holdings, L.P., (ii) 2,718,137 Ordinary Shares of the Issuer held of record by Vivo Opportunity Co-Invest, L.P., and (iii) 4,768,382 Ordinary Shares of the Issuer held of record by Vivo Opportunity Co-Invest (Cycle 3), L.P. Vivo Opportunity Cayman, LLC may be deemed to beneficially own 437,500 Ordinary Shares of the Issuer held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P.
(b)	Percent of class: Vivo Opportunity Fund Holdings, L.P.: 2.5 Vivo Opportunity Co-Invest, L.P.: 1.6 Vivo Opportunity Co-Invest (Cycle 3), L.P.: 2.8 Vivo Opportunity, LLC: 6.9 Vivo Opportunity Cayman Fund, L.P.: 0.3 Vivo Opportunity Cayman, LLC: 0.3 The percentages reported in this Item 4(b) are based on 172,251,411 Ordinary Shares of the Issuer outstanding, which is the sum of (i) 49,290,196 Ordinary Shares outstanding immediately prior to the closing of a private placement by the Issuer on July 28, 2026 (the "Private Placement"), and (ii) 122,961,215 Ordinary Shares issued in the Private Placement, as disclosed in the Securities Purchase Agreement filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 28, 2026.  %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Vivo Opportunity Fund Holdings, L.P.: 4,330,882 Ordinary Shares Vivo Opportunity Co-Invest, L.P.: 2,718,137 Ordinary Shares Vivo Opportunity Co-Invest (Cycle 3), L.P.: 4,768,382 Ordinary Shares Vivo Opportunity, LLC: 11,817,401 Ordinary Shares Vivo Opportunity Cayman Fund, L.P.: 437,500 Ordinary Shares Vivo Opportunity Cayman, LLC: 437,500 Ordinary Shares
	(ii) Shared power to vote or to direct the vote: N/A
	(iii) Sole power to dispose or to direct the disposition of: Vivo Opportunity Fund Holdings, L.P.: 4,330,882 Ordinary Shares Vivo Opportunity Co-Invest, L.P.: 2,718,137 Ordinary Shares Vivo Opportunity Co-Invest (Cycle 3), L.P.: 4,768,382 Ordinary Shares Vivo Opportunity, LLC: 11,817,401 Ordinary Shares Vivo Opportunity Cayman Fund, L.P.: 437,500 Ordinary Shares Vivo Opportunity Cayman, LLC: 437,500 Ordinary Shares
	(iv) Shared power to dispose or to direct the disposition of: N/A
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE
	After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vivo Opportunity Fund Holdings, L.P.

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner Date: 08/04/2026

Vivo Opportunity Co-Invest, L.P.

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner Date: 08/04/2026

Vivo Opportunity Co-Invest (Cycle 3), L.P.

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner Date: 08/04/2026

Vivo Opportunity, LLC

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member Date: 08/04/2026

Vivo Opportunity Cayman Fund, L.P.

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner Date: 08/04/2026

Vivo Opportunity Cayman, LLC

Signature: /s/ Kevin Dai Name/Title: Kevin Dai/Managing Member Date: 08/04/2026

Exhibit 99.1

JOINT FILING AGREEMENT

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.